Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03262181
Other study ID # 17-1731
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 15, 2017
Est. completion date April 20, 2018

Study information

Verified date February 2019
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine differences in lower extremity landing biomechanics and real-world physical activity between individuals with patellar tendinopathy compared to individuals without patellar tendinopathy,and to determine the acute effects of an isometric loading intervention on lower extremity landing biomechanics in individuals with patellar tendinopathy.


Recruitment information / eligibility

Status Completed
Enrollment 43
Est. completion date April 20, 2018
Est. primary completion date April 20, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 15 Years to 28 Years
Eligibility Inclusion Criteria:

The investigators will recruit a convenience sample of participants who meet the following overall criteria:

1. Age 15 and post-pubertal (confirmed by Pubertal Development Scale Questionnaire) - 28 years

2. Actively participating within an organized sport setting (high school, collegiate, club, competitive intramural sports) in their respective team's weekly training and competitions, quantified by a Tegner Activity Level Scale of at least 5.

Exclusion Criteria:

The following exclusion criteria will be applied to all participants:

1. Any anterior knee pain with no patellar tendon abnormality on ultrasound assessment.

2. History of any knee joint surgery ever.

3. History of other (non-knee) lower extremity surgery in the last 1 year.

4. History of lower extremity injury in last 6 months (other than patellar tendinopathy).

5. An injection (corticosteroids, plasma-rich-protein, etc.) to the patellar tendon in the last 3 months.

6. Known history of osteoarthritis or current symptoms related to osteoarthritis (i.e. stiffness, swelling).

7. Participation in formal rehabilitation for patellar tendinopathy in prior 3 months

8. Known neurological disorders, including: stroke, multiple sclerosis, ALS, diabetic neuropathy, epilepsy, traumatic brain injury resulting in loss of consciousness, concussion within the last 6 months, cranial neural surgery, balance disorders.

9. Use of pacemaker or another implantable electronic device.

10. History of cardiac arrhythmia or any cardiac condition.

11. History of psychiatric disorder. *

12. History of cancer in the brain or thigh musculature.

13. Pubertal Development Scale Score < 12 (Stages 1-4)

- Note: Rationale for exclusion of individuals with a history of psychiatric disorders is that these individuals may have taken or be taking pharmacological agents that could affect pain or neuromuscular control.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Isometric Exercise
5 sets of 45-seconds quadriceps contraction, each followed by 2-minutes of rest.
Sham Transcutaneous Electrical Nerve Stimulation
5 sets of 45-seconds intervals without quadriceps contraction, each followed by 2-minutes of rest.

Locations

Country Name City State
United States Sports Medicine Research Laboratory Chapel Hill North Carolina

Sponsors (2)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill Foundation for Physical Therapy, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in the change in mean internal knee extension moment during landing between groups Angular force or moment will be measured in Nm/kg*m where "Nm" represents angular force and "kg*m" represents normalization to body weight and height. Pre- and post-intervention condition (~30 minutes)
Primary Difference in the change in mean internal hip flexion moment during landing between groups Angular force or moment will be measured in Nm/kg*m where "Nm" represents angular force and "kg*m" represents normalization to body weight and height. Pre- and post-intervention condition (~30 minutes)
Primary Difference in the change in mean peak vertical ground reaction force during landing between groups Vertical ground reaction force will be measured in N(BW) where "N" is a measure of force and "BW" represents normalization to body weight. Pre- and post-intervention condition (~30 minutes)
Primary Difference in the change in mean peak vertical ground reaction force loading rate during landing between groups Vertical ground reaction force loading rate will be measured in N(BW)/s where "N" is a measure of force and "BW" represents normalization to body weight and "s" is the time unit seconds. Pre- and post-intervention condition (~30 minutes)
Primary Difference in the change in mean peak patellar tendon force during landing between groups Patellar tendon force will be measured in N(BW) where "N" is a measure of force and "BW" represents normalization to body weight. Pre- and post-intervention condition (~30 minutes)
Secondary Difference in average steps-per-day between groups Steps-per-day calculated by an ActiGraph GT9X Link Accelerometer (ActiGraph Corporation, Pensacola, FL) wearable physical activity device worn at the hip using a belt clip. Day 1 - Day 7
Secondary Difference in average minutes of moderate-to-vigorous physical activity (MVPA) between groups MVPA calculated by an ActiGraph GT9X Link Accelerometer (ActiGraph Corporation, Pensacola, FL) wearable physical activity device worn at the hip using a belt clip. Day 1 - Day 7
Secondary Difference in change in anterior knee pain (self-reported via visual analog scale (0-10)) between groups A standard visual analog scale (0-10) will be utilized to assess pain, where 0=complete absence of pain and 10=worst pain imaginable (higher scores indicate worse pain). This scale will be delivered verbally and the participants will respond verbally. Pre- and post-intervention condition (~10 minutes)
See also
  Status Clinical Trial Phase
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT03307499 - NeoPatch Used as Adjunct in Foot and Ankle Tendon Surgery N/A
Completed NCT02499484 - Topical Glyceryl Trinitrate (GTN) and Eccentric Exercises in the Treatment of Midportion Achilles Tendinopathy N/A
Completed NCT01944150 - Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis N/A
Recruiting NCT04578418 - Effect of Collagen Supplementation on Tendinopathy N/A
Completed NCT03502434 - A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers Phase 1
Recruiting NCT04278833 - Comparative Effectiveness of Particulate Versus Nonparticulate Steroid Injections for Musculoskeletal Conditions Phase 4
Completed NCT05897866 - Sayed Issa's Hybrid Shoulder Arthroscopic-Open Surgical Management (HSSM) N/A
Recruiting NCT05603468 - Effect of PRP vs Corticosteroid in Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair Phase 4
Terminated NCT01544244 - The Global Shoulder Concept (GSC) Method Versus Classic Physical Therapy for Shoulder Tendinitis N/A
Recruiting NCT04144946 - Identification of Early Changes in Patellar Tendinopathy Using Ultra-high Field Strength MRI
Terminated NCT02978833 - Platelet-rich Plasma vs. Whole Blood for Gluteus Medius Tendinopathy Phase 4
Completed NCT03229291 - A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SM04755 Following Topical Administration to Healthy Subjects Phase 1
Recruiting NCT06056440 - Efficacy of a Physical Rehabilitation Program Using Virtual Reality in Patients With Chronic Tendinopathy (Virtendon-Rehab) N/A
Recruiting NCT04058509 - Clinical Predictors of Extracorporal Shockwave Therapy Efficacy in Patients Presenting With Lateral Hip Pain N/A
Withdrawn NCT02981394 - Clinical Outcomes of Autologous Bone Marrow Aspirate Concentrate Injections for Musculoskeletal Conditions
Active, not recruiting NCT02600910 - Natural History of Shoulder Pathology in Manual Wheelchair Users
Completed NCT04793971 - Minimal Invasive Treatment of Achilles Tendinopathy: Focus on Percutaneous Release (Maffulli)
Not yet recruiting NCT01225497 - Eccentric Exercise for Chronic Mid-portion Achilles Tendinopathy N/A
Completed NCT04067479 - Can Amino Acid Supplementation Augment the Anabolic Response in Tendon After Exercise N/A